Height improvement by L-thyroxine treatment in subclinical hypothyroidism

Subclinical hypothyroidism(SH) is most commonly an early stage of hypothyroidism. Although the condition may resolve or remain unchanged, within a few years in some patients overt hypothyroidism develops, with low free T4 levels as well as a raised thyroid stimulating hormone (TSH) level. Patients w...

Full description

Saved in:
Bibliographic Details
Published inPediatrics international Vol. 45; no. 5; pp. 534 - 537
Main Authors Cetinkaya, Ergun, Aslan, AyseTana, Vidinlisan, Sadi, Ocal, Gonul
Format Journal Article
LanguageEnglish
Published Australia 01.10.2003
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Subclinical hypothyroidism(SH) is most commonly an early stage of hypothyroidism. Although the condition may resolve or remain unchanged, within a few years in some patients overt hypothyroidism develops, with low free T4 levels as well as a raised thyroid stimulating hormone (TSH) level. Patients with SH may have subtle hypothyroid symptoms with mild abnormalities of serum lipoproteins and cardiac functions. L-thyroxine in a dosage that maintains serum TSH levels within the normal range is the preferred therapy in these patients. Although short stature is a well-known clinical sign of overt hypo-thyroidism,the effect of SH in growth is not well established. The aim of the present study is to show the effect of treatment on height in these patients. In the present study, 2067 patients who were admitted to the Endocrinology Department of SSK Ankara Children's Hospital, Ankara, Turkey, with the complaint of short stature were evaluated and 39 were diagnosed with SH by thyrotropin releasing hormone stimulation test. The anthropometric data of the patients who were subdivided into two groups (prepubertal and pubertal) were analyzed before and after 6-12 months of L-thyroxine treatment. Growth velocity (GV) and GV standard deviation score(GVSDS) of the groups before and after the treatment were statistically analyzed. Both groups showed significant increases in GV and GVSDS by L-thyroxine treatment. Patients with short stature have to be evaluated for SH in addition to other potential causes. L-thyroxine treatment in these patients provides significant improvement in height.
AbstractList BACKGROUNDSubclinical hypothyroidism(SH) is most commonly an early stage of hypothyroidism. Although the condition may resolve or remain unchanged, within a few years in some patients overt hypothyroidism develops, with low free T4 levels as well as a raised thyroid stimulating hormone (TSH) level. Patients with SH may have subtle hypothyroid symptoms with mild abnormalities of serum lipoproteins and cardiac functions. L-thyroxine in a dosage that maintains serum TSH levels within the normal range is the preferred therapy in these patients. Although short stature is a well-known clinical sign of overt hypo-thyroidism,the effect of SH in growth is not well established. The aim of the present study is to show the effect of treatment on height in these patients. METHODSIn the present study, 2067 patients who were admitted to the Endocrinology Department of SSK Ankara Children's Hospital, Ankara, Turkey, with the complaint of short stature were evaluated and 39 were diagnosed with SH by thyrotropin releasing hormone stimulation test. The anthropometric data of the patients who were subdivided into two groups (prepubertal and pubertal) were analyzed before and after 6-12 months of L-thyroxine treatment. Growth velocity (GV) and GV standard deviation score(GVSDS) of the groups before and after the treatment were statistically analyzed. RESULTSBoth groups showed significant increases in GV and GVSDS by L-thyroxine treatment. CONCLUSIONPatients with short stature have to be evaluated for SH in addition to other potential causes. L-thyroxine treatment in these patients provides significant improvement in height.
Subclinical hypothyroidism(SH) is most commonly an early stage of hypothyroidism. Although the condition may resolve or remain unchanged, within a few years in some patients overt hypothyroidism develops, with low free T4 levels as well as a raised thyroid stimulating hormone (TSH) level. Patients with SH may have subtle hypothyroid symptoms with mild abnormalities of serum lipoproteins and cardiac functions. L-thyroxine in a dosage that maintains serum TSH levels within the normal range is the preferred therapy in these patients. Although short stature is a well-known clinical sign of overt hypo-thyroidism,the effect of SH in growth is not well established. The aim of the present study is to show the effect of treatment on height in these patients. In the present study, 2067 patients who were admitted to the Endocrinology Department of SSK Ankara Children's Hospital, Ankara, Turkey, with the complaint of short stature were evaluated and 39 were diagnosed with SH by thyrotropin releasing hormone stimulation test. The anthropometric data of the patients who were subdivided into two groups (prepubertal and pubertal) were analyzed before and after 6-12 months of L-thyroxine treatment. Growth velocity (GV) and GV standard deviation score(GVSDS) of the groups before and after the treatment were statistically analyzed. Both groups showed significant increases in GV and GVSDS by L-thyroxine treatment. Patients with short stature have to be evaluated for SH in addition to other potential causes. L-thyroxine treatment in these patients provides significant improvement in height.
Author Vidinlisan, Sadi
Ocal, Gonul
Cetinkaya, Ergun
Aslan, AyseTana
Author_xml – sequence: 1
  givenname: Ergun
  surname: Cetinkaya
  fullname: Cetinkaya, Ergun
  email: ergunckaua@hotmail.com
  organization: Pediatric Endocrinology Department, SSK Ankara Children's Hospital, Diskapi Turkey. ergunckaua@hotmail.com
– sequence: 2
  givenname: AyseTana
  surname: Aslan
  fullname: Aslan, AyseTana
– sequence: 3
  givenname: Sadi
  surname: Vidinlisan
  fullname: Vidinlisan, Sadi
– sequence: 4
  givenname: Gonul
  surname: Ocal
  fullname: Ocal, Gonul
BackLink https://www.ncbi.nlm.nih.gov/pubmed/14521527$$D View this record in MEDLINE/PubMed
BookMark eNo1jz1PwzAYhD0U0Q_4C8gTW4K_7YyoAopUiaUDW2Qnb6irxCmxg5p_T1XKcjfco9PdEs1CHwAhTElOiVBPh5wKwTJGyGd-Fp4Tqo3KTzO0oJyZzBCl52gZ44EQYrQRt2hOhWRUMr1A7xvwX_uEfXcc-h_oICTsJrzN0n4a-pMPgNMANl0CH3AcXdX64Cvb4v107C-Yr33s7tBNY9sI91dfod3ry269ybYfb-_r5212YIqkTAMvGme0lYVmQilX1M4VlMqGWlIxzmwjnCOFokxKzqGxyigK2lZQM-P4Cj3-1Z73fo8QU9n5WEHb2gD9GEsttRBG8TP4cAVH10FdHgff2WEq_7_zXw1HXms
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1046/j.1442-200X.2003.01786.x
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 537
ExternalDocumentID 14521527
Genre Clinical Trial
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29O
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CGR
COF
CS3
CUY
CVF
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
ECM
EIF
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NPM
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZZTAW
~IA
~WT
7X8
ID FETCH-LOGICAL-j260t-7e39fb87a5972466b9dbb9115f1a0c232af4bb096125533efa6861e7aced28b3
ISSN 1328-8067
IngestDate Fri Aug 16 01:56:50 EDT 2024
Sat Sep 28 07:48:37 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j260t-7e39fb87a5972466b9dbb9115f1a0c232af4bb096125533efa6861e7aced28b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 14521527
PQID 75744863
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_75744863
pubmed_primary_14521527
PublicationCentury 2000
PublicationDate 2003-Oct
20031001
PublicationDateYYYYMMDD 2003-10-01
PublicationDate_xml – month: 10
  year: 2003
  text: 2003-Oct
PublicationDecade 2000
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle Pediatrics international
PublicationTitleAlternate Pediatr Int
PublicationYear 2003
SSID ssj0008784
Score 1.8786019
Snippet Subclinical hypothyroidism(SH) is most commonly an early stage of hypothyroidism. Although the condition may resolve or remain unchanged, within a few years in...
BACKGROUNDSubclinical hypothyroidism(SH) is most commonly an early stage of hypothyroidism. Although the condition may resolve or remain unchanged, within a...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 534
SubjectTerms Body Height - drug effects
Child
Humans
Hypothyroidism - drug therapy
Thyroxine - therapeutic use
Treatment Outcome
Title Height improvement by L-thyroxine treatment in subclinical hypothyroidism
URI https://www.ncbi.nlm.nih.gov/pubmed/14521527
https://search.proquest.com/docview/75744863
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkRCXivJsS2EP3JCr2Ou118eKhwKiHFBAuUX7MrjAOoodifDrO_vw2ohWAi5RZEeOtd-n2ZnZmW8Qep6nNcQVgieKV7Mkp5QkLJVVQgWHDYKLjErbjXz-oZh_yt8t6XIsYnfdJb04lb-u7Cv5H1ThGuBqu2T_Adn4ULgA3wFf-ASE4fOvMJ67vKbtdNy0Tve7t97k-wQWf9P-tP7jWEfemBfdVsRGyK-7det-1qhBRDC4qHF4R-e0JGK6MJ5W2Cbpb3zHvRn9so30OgN6eUWCXacX3ESL_xn-xHxvupBs5aqJuV3J_YSv1oQKxSEDMdayDUaTZAx2Oj9WY7CqXiQysIdOTCT1ycs_TPfMaRa70-bMorx0Yq2nYDFY4Us6J4iufzhI05y6ubzjZhZLDIdbN9GtrKyojctffRyVxVjJ_Lzj8OqhyCseeF_xClZfNjz0-nDEuSWLu2g_xBP4zJPjAN3Q5h66fR4qJu6jt54jeMIRLHZ4whEcOYIbgyccwb9z5AFavHm9eDlPwviM5AKC1D4pNalqwUoOMWOWF4WolBCwt9E65TMJnjSvcyHsyB8IKwnRNS9YkeqSS60yJshDtGdaox8jnNdVJguhSlmRfKZkJXWqpCZMQWzGa32Ing3LsQLrZI-cuNHttluVtIT4vyCH6JFfpdXai6ishqU8uvbOMbozsu0J2us3W30CHmAvnjosLwGF1VrQ
link.rule.ids 315,786,790,27957,27958
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Height+improvement+by+L-thyroxine+treatment+in+subclinical+hypothyroidism&rft.jtitle=Pediatrics+international&rft.au=Cetinkaya%2C+Ergun&rft.au=Aslan%2C+AyseTana&rft.au=Vidinlisan%2C+Sadi&rft.au=Ocal%2C+Gonul&rft.date=2003-10-01&rft.issn=1328-8067&rft.volume=45&rft.issue=5&rft.spage=534&rft_id=info:doi/10.1046%2Fj.1442-200X.2003.01786.x&rft_id=info%3Apmid%2F14521527&rft.externalDocID=14521527
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1328-8067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1328-8067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1328-8067&client=summon